“…Most participants in studies of neurocognitive endophenotypes for mood disorder subgroups have been recruited in clinical settings that represent the most severe cases (Bora et al, 2009; Volkert et al, 2016), often during the acute phase of mood disorders that may be complicated by affective state and medication use (Burdick et al, 2014; de Brito Ferreira Fernandes et al, 2016; Georgiades et al, 2016; Glahn et al, 2010; Lee et al, 2014; Xu et al, 2012). Associations found in these studies differ by source of the samples, mood disorder subgroups (Godard et al, 2011), clinical characteristics including current state (Martinez-Aran et al, 2004), medication use, psychotic features, severity, consequences (Jaeger et al, 2006; Martinez-Aran et al, 2007; Ruggero et al, 2007) or precursors of the disorder (Pavuluri et al, 2006), as well as substantial differences in the measures and domains assessed (Porter et al, 2015).…”